peptideand
proteinnanoparticl
conjug
emerg
power
tool
biomed
applic
enabl
treatment
diagnosi
prevent
diseas
review
focu
key
role
play
peptid
protein
improv
control
defin
perform
nanotechnolog
within
framework
provid
comprehens
overview
key
sequenc
structur
utilis
provid
biolog
physic
stabil
nanoconstruct
direct
particl
target
influenc
cellular
tissu
distribut
induc
control
biolog
respons
form
polypeptid
selfassembl
nanoparticl
highlight
great
advanc
made
field
well
challeng
still
face
achiev
clinic
translat
peptideand
proteinfunctionalis
nanodrug
deliveri
vehicl
imag
speci
activ
therapeut
pharmacokinet
enabl
tissu
target
promot
cell
tissu
penetr
similarli
np
drug
deliveri
vehicl
offer
sever
benefit
use
proteinand
antibodydrug
conjug
adc
emerg
last
year
promis
clinic
tool
treatment
rang
diseas
particular
np
platform
offer
possibl
incorpor
multipl
function
within
singl
construct
result
problem
poor
tumour
penetr
often
exhibit
adc
overcom
describ
section
furthermor
encapsul
therapeut
agent
allow
need
cleavabl
linkag
avoid
enabl
high
level
drug
deliv
everi
recognit
event
benefit
bare
np
decor
polypeptid
also
wide
exploit
field
vivo
imag
compar
small
molecul
imag
agent
np
often
offer
advantag
greatli
improv
signaltonois
ratio
stabl
signal
gener
high
spectral
resolut
multiplex
detect
abil
display
multimod
signal
gener
result
np
found
increas
util
imag
rang
modal
includ
nearinfrar
nir
fluoresc
magnet
reson
imag
mri
positron
emiss
tomographi
pet
inde
mani
npbase
imag
technolog
routin
use
clinic
set
stimuli
respons
np
also
find
increas
util
within
biomed
field
often
lead
localis
destruct
patholog
tissu
whether
result
magnet
light
induc
hyperthermia
npmediat
photoabl
technolog
strongli
reliant
adequ
accumul
site
treatment
mani
system
reli
inorgan
core
vital
reduc
leach
metal
compon
due
associ
toxic
result
peptid
protein
coat
direct
stabilis
eventu
lead
clearanc
therapeut
np
key
compon
emerg
technolog
approach
clinic
applic
np
found
widespread
use
across
materi
physic
engin
biolog
scienc
number
new
technolog
increas
exponenti
rate
particl
structur
enabl
applic
equal
divers
precis
control
materi
architectur
design
enabl
broad
spectrum
tunabl
properti
depend
end
applic
despit
larg
variat
number
np
format
found
particular
util
biomed
field
much
research
discuss
within
review
focuss
use
main
categori
np
though
mani
other
also
utilis
nich
set
peptidebas
np
discuss
section
briefli
introduc
order
contextualis
discuss
follow
tabl
gold
nanoparticl
aunp
aunp
attract
structur
biomed
applic
one
stabl
least
toxic
metal
np
formul
aunp
offer
safe
effect
diagnost
therapeut
tool
abil
thiol
form
stabl
linkag
surfac
aunp
allow
versatil
surfac
chemistri
achiev
decor
particl
surfac
wide
rang
biomolecul
enabl
biodistribut
physic
properti
intracellular
fate
modul
furthermor
aunp
exhibit
uniqu
optic
electron
properti
concert
electron
oscil
follow
excit
lead
strong
light
emiss
via
localis
surfac
plasmon
reson
lspr
interact
light
strongli
depend
size
shape
surfac
chemistri
aggreg
environ
properti
enabl
use
aunp
rang
imag
modal
includ
nir
fluoresc
photoacoust
imag
xray
comput
tomographi
well
find
util
photoabl
hypertherm
therapi
ii
magnet
nanoparticl
mnp
mnp
compos
predominantli
magneticallyrespons
element
iron
nickel
cobalt
variou
differ
form
find
increas
util
biomed
field
iron
oxid
particl
found
widespread
use
particularli
high
contrast
imag
agent
mri
applic
altern
magnet
field
also
utilis
minim
invas
stimuli
gener
hyperthermia
describ
final
inher
magnet
mnp
enabl
spatial
distribut
easili
manipul
allow
guid
deliveri
drugcontain
vehicl
iii
semiconduct
np
quantum
dot
qd
order
undertak
fluoresc
imag
vivo
advantag
emiss
nir
allow
tissu
penetr
convent
small
molecul
nir
fluorophor
suffer
poor
photost
high
hydrophob
hinder
distribut
weak
signaltonois
gener
contrast
semiconduct
np
particular
qd
possess
narrow
sizetun
high
quantum
yield
emiss
furthermor
excit
broad
wavelength
light
display
greatli
improv
resist
photobleach
chemic
degrad
therefor
highli
attract
structur
undertak
biomed
imag
howev
high
toxic
cadmium
metal
common
mani
qd
formul
necessit
use
stabl
coat
abl
prevent
leach
biolog
milieu
iv
mesopor
silica
nanoparticl
msnp
msnp
possess
tunabl
pore
size
larg
surfac
area
high
pore
volum
therefor
attract
drugdeliveri
vehicl
abil
encapsul
larg
payload
cargo
rang
small
molecul
larg
protein
eas
surfac
modif
costeffect
scalabl
product
add
attract
msnp
furthermor
classif
silica
gener
recogn
safe
substanc
unit
state
food
drug
administr
fda
greatli
facilit
regulatori
approv
msnp
technolog
though
question
longterm
effect
biodegrad
biocompat
mani
silica
nanotechnolog
remain
unansw
addit
applic
drug
deliveri
msnp
also
found
widespread
use
imag
agent
consequ
abil
encapsul
concentr
contrast
agent
wide
rang
modal
v
liposom
liposom
spheric
vesicl
commonli
compos
least
one
bilay
selfassembl
phospholipid
similar
liposom
bilay
cell
membran
particularli
attract
drug
deliveri
applic
inde
liposom
perhap
mostli
wide
use
investig
np
carrier
drug
deliveri
amongst
first
npbase
technolog
enter
clinic
liposom
abl
encapsul
hydrophil
cargo
within
aqueou
interior
hydrophob
within
membran
bilay
furthermor
liposom
readili
functionalis
lipid
hydrocarbon
functionalis
ligand
make
stabl
costeffect
attract
tool
biomed
applic
vi
polym
nanoparticl
versatil
synthet
polym
enabl
wide
rang
particl
architectur
endappl
explor
polym
vesicl
commonli
refer
polymersom
micel
compos
selfassembl
amphiphil
block
copolym
particularli
attract
due
abil
encapsul
cargo
analog
fashion
correspond
lipid
analogu
np
size
membran
thick
poros
mani
factor
tune
adjust
block
length
pendant
group
functionalis
furthermor
design
flexibl
enabl
synthet
polym
chemistri
enabl
introduct
stimulirespons
biolog
activ
function
abl
modul
particl
properti
smart
predict
manner
polym
np
find
increas
use
across
number
biomed
disciplin
tabl
commonli
use
np
biomed
applic
particl
type
advantag
disadvantag
gold
np
eas
surfac
modif
activ
rang
imag
modal
size
depend
properti
utilis
photodynam
therapi
nonbiodegrad
potenti
low
colloid
stabil
magnet
np
activ
highcontrast
mri
imag
guid
magnet
utilis
photodynam
therapi
cytotox
poor
biocompat
nonbiodegrad
semiconduct
np
qd
size
tunabl
high
quantum
yield
emiss
resist
bleach
degrad
broad
wavelength
excit
narrow
emiss
allow
multiplex
fluoresc
sensit
surfac
functionalis
toxic
metal
compon
nonbiodegrad
mesopor
silica
np
control
poros
biodegrad
high
load
capac
cargo
deliveri
eas
surfac
modif
potenti
toxic
degrad
product
liposom
low
immunogen
high
biocompat
eas
function
flexibl
formul
tune
structur
encapsul
hydrophil
hydrophob
cargo
low
load
effici
valuabl
cargo
poor
stabil
prone
leakag
polym
np
versatil
function
structur
eas
modif
tunabl
made
degrad
stimuli
respons
potenti
toxic
np
degrad
product
figur
retent
differ
size
qd
hr
intraven
inject
particl
diamet
rapidli
clear
kidney
larger
particl
retain
adapt
soo
choi
et
al
permiss
natur
publish
group
peptid
protein
coat
use
improv
upon
biolog
stabil
deliv
np
address
difficulti
alter
interact
host
cell
circul
biomolecul
peptideprotein
coat
modul
control
tissu
accumul
ensur
np
activ
figur
order
understand
achiev
import
first
understand
factor
induc
clearanc
adsorpt
opsonin
plasma
protein
immunoglobulin
g
complement
factor
fibrinogen
np
surfac
play
promin
role
trigger
clearanc
induc
macrophag
recognit
subsequ
elimin
via
phagocytosi
inhibit
process
recognit
remov
np
immun
system
reduc
contrast
protein
corona
enrich
serum
albumin
lipoprotein
often
refer
dysopsonin
recognit
block
circul
time
increas
amongst
np
properti
known
promot
clearanc
surfac
charg
hydrophob
particularli
import
although
conflict
report
exist
rel
clearanc
rate
posit
neg
charg
particl
becom
appar
nearneutr
charg
may
fact
favour
time
reduct
hydrophob
also
shown
key
paramet
reduc
uptak
np
macrophag
benefici
biolog
perspect
import
note
particl
exhibit
neutral
low
surfac
charg
often
exhibit
reduc
colloid
stabil
discuss
subsequ
section
therefor
import
consid
delic
balanc
determin
np
fate
design
peptideprotein
coat
figur
upon
enter
bodi
np
quickli
acquir
protein
corona
exact
composit
corona
dynam
highli
depend
environ
initi
corona
form
typic
highli
abund
protein
b
weakli
bound
protein
gradual
remov
protein
higher
affin
np
surfac
c
adsorpt
protein
depend
alreadi
exist
coat
interprotein
well
proteinnp
interact
determin
affin
gradual
stabl
coat
strongli
adsorb
protein
form
creat
hard
protein
corona
reproduc
monopoli
et
al
permiss
natur
publish
group
one
wide
utilis
method
limit
opsonis
np
clearanc
circul
use
stealth
polym
poli
ethylen
glycol
peg
form
protect
layer
around
np
neutral
surfac
charg
confer
hydrophil
provid
steric
barrier
adsorpt
howev
fine
line
provid
coat
improv
biodistribut
diminish
interact
target
cell
tissu
coat
np
peg
associ
reduc
cellular
uptak
thu
therapeut
efficaci
gener
pegspecif
antibodi
acceler
clearanc
blood
preferenti
accumul
liver
spleen
versatil
peptid
design
thu
offer
attract
altern
coat
figur
use
nonion
peptid
offer
zwitterion
balanc
charg
may
particularli
use
reduc
clearanc
follow
strategi
guerrero
et
al
conjug
amphipath
peptid
clpffd
previous
shown
mediat
transport
across
bloodbrain
barrier
aunp
aim
increas
particl
deliveri
central
nervou
system
reduc
neg
charg
rel
citratecap
aunp
deliveri
brain
improv
accumul
spleen
also
reduc
howev
approach
gener
applic
similar
studi
aunp
coat
weakli
neg
charg
cellpenetr
peptid
although
enabl
improv
cell
deliveri
due
presenc
preferenti
accumul
also
observ
within
spleen
similarli
morai
et
al
report
coat
aunp
calnn
led
increas
clearanc
liver
accumul
compar
citratecap
particl
result
highlight
difficulti
predict
pharmacokinet
properti
often
appar
similar
peptid
sequenc
drastic
differ
effect
clearanc
conclus
strongli
support
research
poon
et
al
reveal
complex
design
peptidenp
conjug
escap
bodi
reticuloendotheli
system
coat
aunp
mixtur
peg
either
neg
charg
therapeut
peptid
myx
posit
charg
crgd
target
peptid
found
effect
pegpeptid
coat
could
act
independ
synergist
depend
sequenc
employ
import
evalu
np
pharmacokinet
casebycas
basi
altern
approach
avoid
clearanc
reli
biolog
signal
enhanc
retent
promin
achiev
use
membran
protein
interact
signalregulatori
protein
alpha
trigger
downstream
antiphagocyt
process
act
effect
marker
self
send
eat
signal
figur
peptid
deriv
mimic
effect
thu
design
shown
reduc
phagocytosi
importantli
peptid
coat
np
display
greatli
reduc
accumul
liver
spleen
enhanc
accumul
cancer
tissu
follow
intraven
inject
figur
similarli
qie
et
al
recent
demonstr
np
functionalis
fulllength
also
abl
modul
clearanc
time
enabl
evas
differ
macrophag
popul
howev
work
also
highlight
need
better
understand
interact
nanomateri
macrophag
display
distinct
phenotyp
order
pave
way
truli
immunolog
inert
nanomateri
figur
schemat
demonstr
main
mechan
np
uptaken
subsequ
intracellularli
process
cell
exact
mechan
taken
particular
particl
highli
depend
precis
np
characterist
polypeptid
coat
layer
target
cell
type
environ
situat
complic
abil
particl
exploit
multipl
differ
uptak
pathway
parallel
adapt
permiss
zhu
et
al
key
peptid
sequenc
estim
excess
uniqu
peptid
identifi
abl
promot
cell
penetr
vitro
experi
hand
promin
sequenc
close
relat
analogu
translat
biomed
applic
although
mani
possibl
explan
pauciti
peptid
use
set
factor
particular
import
firstli
mani
sequenc
induc
toxic
particularli
amphipath
peptid
often
induc
membran
disrupt
order
promot
uptak
secondli
perhap
importantli
effici
best
cpp
peptid
abl
deliv
cargo
difficult
improv
upon
penetr
effici
even
properti
leav
lot
desir
describ
commonli
utilis
method
mediat
internalis
reli
highli
cation
peptid
sequenc
abl
first
strongli
bind
neg
charg
cell
membran
induc
transport
via
either
direct
endocyt
pathway
group
includ
ubiquit
human
immunodefici
viru
hiv
deriv
tat
peptid
well
synthet
polyarginin
penetratin
deriv
drosophila
antennapedia
homeodomain
sequenc
inde
cpp
utilis
vivo
deliveri
np
substrat
fall
almost
exclus
categori
schwarz
et
al
demonstr
conjug
tat
protein
substrat
could
use
deliv
cargo
part
bodi
sinc
initi
report
number
np
cargo
system
deliv
cell
indiscrimin
preferenti
localis
determin
mere
np
pharmacokinet
passiv
accumul
np
tumour
also
exploit
allow
preferenti
deliveri
tatlabel
drugload
micel
chitosan
np
well
antitumour
silver
np
tumour
cell
anim
vivo
model
figur
similarli
argininerich
peptid
penetratin
use
penetr
tumour
cell
follow
passiv
accumul
target
brain
cover
section
interestingli
nonnatur
denantiom
tat
also
shown
mediat
cell
penetr
strongli
suggest
np
uptak
result
tat
decor
due
use
nanoparticl
np
provid
new
opportun
develop
effect
safe
commerciallyvi
biomed
technolog
whether
drugdeliveri
vehicl
highcontrast
imag
agent
activ
therapeut
np
enabl
new
approach
taken
treatment
diagnosi
monitor
diseas
within
human
bodi
unfunctionalis
np
construct
often
abl
fulfil
desir
function
control
vitro
set
howev
complex
environ
human
bodi
mani
question
still
remain
particl
target
site
diseas
clearanc
avoid
ensur
suitabl
therapeut
lifetim
accumul
biomolecular
corona
diminish
activ
recent
decad
format
peptideor
proteinnp
conjug
emerg
vital
tool
address
mani
difficulti
aris
result
consider
hybrid
materi
enabl
favour
characterist
nanos
structur
combin
biolog
activ
biocompat
versatil
natur
deriv
synthet
polypeptid
review
provid
comprehens
overview
develop
use
peptideproteinnp
conjug
biomedicin
mani
review
previous
publish
method
creat
np
conjug
subsequ
applic
within
bodi
specif
featur
impart
peptid
protein
np
conjug
less
wide
discuss
therefor
focu
distinct
role
play
peptideprotein
improv
control
defin
perform
nanotechnolog
figur
deliv
detail
refer
expert
new
field
np
technolog
alik
furthermor
hope
stimul
discuss
innov
within
field
order
overcom
mani
difficulti
continu
hinder
clinic
translat
potenti
power
tool
uniqu
properti
size
regim
np
offer
mani
benefit
small
molecul
larger
micrometr
size
particl
wide
exploit
within
biomed
field
review
extens
elsewher
way
context
review
briefli
summaris
key
factor
make
npbase
technolog
particularli
attract
role
predominantli
appli
one
promin
realm
np
system
found
util
vehicl
drug
deliveri
small
molecul
drug
often
suffer
poor
pharmacokinet
exhibit
rapid
clearanc
difficulti
reach
desir
siteofact
vivo
result
sever
sideeffect
may
accompani
therapeut
benefit
common
vitro
efficaci
poorli
translat
clinic
set
abil
np
solubilis
therapeut
molecul
enhanc
retent
circul
promot
accumul
target
tissu
make
attract
vehicl
overcom
limit
hinder
drug
discoveri
process
effect
enhanc
incorpor
peptid
protein
coat
focu
review
improv
strike
number
np
system
found
success
applic
biomed
applic
pale
insignific
compar
vast
bodi
literatur
use
np
construct
control
model
set
predominantli
due
signific
challeng
associ
translat
np
stabil
idealis
condit
complex
environ
biolog
relev
scenario
peptid
protein
coat
play
major
role
enabl
np
base
technolog
abil
provid
biolog
physic
stabil
summaris
section
figur
tabl
tabl
importantli
two
factor
necessarili
independ
complementari
discuss
coat
prevent
np
aggreg
may
also
impact
rate
construct
clear
circul
therefor
import
care
consid
design
criteria
order
ensur
endappl
achiev
order
reach
desir
siteofact
np
must
navig
way
around
ensembl
biolog
obstacl
includ
defin
biolog
surfac
endotheli
cell
membran
barrier
permeat
circul
monocyt
macrophag
bodi
immun
system
achiev
function
np
must
circul
bloodstream
long
enough
reach
target
cell
tissu
organ
whilst
avoid
remov
activ
phagocytosi
renal
clearanc
nanoscal
dimens
lead
greatli
alter
pharmacokinet
properti
compar
small
molecul
vivo
exampl
hard
inorgan
particl
renal
clearanc
greatli
reduc
diamet
nm
due
size
cutoff
kidney
urinari
excret
figur
abil
np
modul
pharmacokinet
wide
utilis
mean
improv
retent
biodistribut
vivo
stabil
encapsul
small
molecul
howev
differ
come
without
challeng
depend
size
structur
functionalis
np
detriment
tissu
accumul
occur
uptak
particl
macrophag
lead
rapid
remov
circul
also
induct
unfavour
inflammatori
respons
figur
method
peptideproteinnp
coat
design
influenc
biolog
stabil
decreas
suscept
clearanc
recognit
clearanc
limit
provid
balanc
charg
surfac
hydrophob
b
selfpeptid
recognis
macrophag
use
inhibit
phagocytosi
c
format
protein
corona
modul
provid
stabl
peptideprotein
coat
promot
absorpt
dysopsonin
tune
np
properti
size
shape
charg
iiii
soon
np
introduc
biolog
environ
complic
aris
mixtur
biomacromolecul
interact
particl
surfac
often
mask
effect
particl
strongli
influenc
pharmacokinet
properti
proteinrich
media
blood
new
coat
refer
protein
corona
hard
corona
made
tightlybound
protein
form
thermodynam
favour
interact
np
surfac
follow
soft
corona
rapidli
exchang
protein
figur
natur
biomolecul
coat
highli
depend
environ
thu
difficult
predict
often
result
dramat
loss
activ
function
strongli
influenc
nanomateri
fate
vivo
adsorpt
dysopsonin
known
enhanc
retent
third
approach
improv
np
pharmacokinet
therefor
promot
format
favour
dysopsoninprotein
corona
figur
achiev
either
precoat
np
prior
vivo
applic
tune
np
surfac
properti
promot
enrich
dysopsonin
opsonin
situ
serum
albumin
abund
protein
blood
play
wide
rang
role
includ
act
molecular
protein
transport
maintain
oncot
pressur
buffer
blood
ph
preform
albumin
corona
also
abl
act
prevent
attach
altern
protein
improv
np
stabil
peng
et
al
show
strategi
abl
limit
phagocytosi
prolong
circul
time
vivo
simpl
np
preincub
solut
bovin
serum
albumin
bsa
hydrophobin
exogen
protein
express
fungi
high
affin
np
surfac
also
alter
composit
protein
corona
np
expos
bodili
fluid
high
affin
hydrophobin
enabl
protein
remain
strongli
associ
np
surfac
even
competit
plasma
protein
apolipoprotein
coat
also
shown
increas
np
circul
time
studi
polystyrenenp
coat
demonstr
amino
sulfon
functionalis
particl
coat
led
accumul
high
level
apolipoprotein
result
highlight
import
surfac
charg
function
group
influenc
protein
corona
format
notabl
bind
specif
apolipoprotein
subtyp
also
shown
strongli
influenc
subsequ
cell
uptak
vitro
et
al
demonstr
apolipoprotein
clusterin
also
known
apoj
reduc
nonspecif
cellular
uptak
steric
protect
polymernp
recent
studi
highlight
effect
initi
polym
coverag
downstream
effect
clusterin
abl
shield
np
opsonis
low
peg
densiti
effect
np
clearanc
higher
peg
coverag
downstream
effect
protein
corona
format
must
also
therefor
consid
fibrinogen
circul
glycoprotein
bloodstream
well
known
opsonin
abl
inhibit
cell
adhes
suitabl
concentr
low
fibrinogen
concentr
adsorb
np
surfac
singl
highli
adhes
monolay
form
contrast
dens
coat
high
concentr
reduc
cell
adhes
static
flow
condit
via
format
nanoscal
multilay
matrix
howev
translat
fibrinogen
design
np
coat
increas
circul
remain
challeng
fibrinogen
also
lead
np
aggreg
consequ
format
interparticl
bridg
physic
stabil
np
construct
import
consider
design
biomed
technolog
suitabl
stabil
requir
ensur
particl
abl
fulfil
function
leach
small
molecul
particl
structur
format
accumul
larger
aggreg
must
also
control
minimis
toxic
order
demonstr
abil
np
appli
vitro
vivo
must
form
dispers
stabl
suspens
physiolog
condit
sever
report
demonstr
agglomer
np
drastic
alter
effect
properti
particular
toxic
lead
larg
discrep
experiment
output
inde
aggreg
particl
display
greatli
decreas
surfac
area
reduc
cellular
uptak
compar
dispers
particl
often
lead
underestim
toxic
prior
applic
vivo
contrast
sediment
decreas
diffus
significantli
impact
effect
dose
experienc
cell
vitro
lead
larg
discrep
experiment
readout
significantli
decreas
efficaci
upon
vivo
translat
np
aggreg
also
trigger
opsonis
bloodstream
discuss
make
particl
visibl
phagocytot
system
thu
physic
stabil
biolog
stabil
intim
link
floccul
particl
aqueou
solut
govern
derjaguinlandauverweyoverbeek
theori
dlvo
theori
stabil
dispers
depend
balanc
attract
repuls
forc
particl
becom
unstabl
start
agglomer
repuls
energi
suffici
counteract
van
der
waal
attract
energi
biolog
salt
concentr
situat
becom
complic
howev
basic
stabil
remain
similar
suffici
electrostat
steric
stabil
requir
provid
repuls
energi
prevent
agglomer
biomed
applic
coat
must
provid
colloid
stabil
also
aqueou
solubl
conserv
np
function
format
protein
corona
upon
applic
vivo
may
either
enhanc
compromis
np
colloid
stabil
commonli
steric
bulk
provid
protein
coat
provid
signific
stabilis
limit
interparticl
attract
forc
phenomena
abl
offset
low
contribut
stabilis
electrostat
repuls
forc
larg
negat
presenc
high
electrolyt
concentr
physiolog
condit
peptid
particularli
wide
use
provid
physic
stabilis
metal
semiconductor
particl
high
suscept
aggreg
must
care
mitig
exampl
depend
cap
layer
utilis
unfunctionalis
aunp
incred
sensit
environment
chang
small
chang
ph
salt
concentr
temperatur
presenc
biomolecul
often
lead
rapid
irrevers
aggreg
combinatori
design
peptid
sequenc
identifi
abl
find
care
balanc
charg
polar
function
hydrophob
length
et
al
identifi
pentapeptid
calnn
librari
watersolubl
peptid
abl
provid
extrem
stabl
aunp
follow
surfac
functionalis
presenc
ntermin
cystein
enabl
facil
functionalis
particl
surfac
rest
sequenc
provid
dens
pack
neg
charg
peptid
corona
abl
withstand
aggreg
abil
thiol
bind
metal
surfac
led
cystein
cap
peptid
wide
utilis
cap
agent
metal
np
inde
peptid
calnn
use
core
peptid
addit
biolog
function
attach
provid
stabl
peptidefunctionalis
inner
corona
bear
pendant
peptid
direct
influenc
np
activ
howev
although
cysteinemet
bind
suffici
provid
stabilis
np
vitro
revers
thiolmet
bond
format
mean
ligand
exchang
occur
although
concentr
free
thiol
blood
far
lower
observ
intracellularli
remain
high
enough
induc
loss
monothiol
coat
circul
part
due
possibl
dissoci
ligand
exchang
pathway
ligand
rapidli
dilut
within
serum
upon
dissoci
replac
circul
small
molecul
thiol
addit
high
level
serum
albumin
blood
contain
singl
reduc
cystein
residu
shown
mediat
ligand
exchang
biolog
sampl
loss
np
coat
lead
two
often
concurr
outcom
dilut
regim
provid
vivo
set
replac
initi
thiol
coat
thiolat
biomolecul
lead
loss
function
impart
cap
layer
discuss
throughout
review
ii
loss
stabil
effect
provid
cap
layer
ligand
gradual
lost
result
increasingli
stabilis
peptid
coat
explor
recent
year
often
achiev
use
multident
bind
site
use
multipl
cystein
residu
unnatur
amino
acid
bear
dithiol
motif
provid
multipl
anchor
point
metal
surfac
individu
peptid
figur
even
revers
desorpt
one
thiol
group
metal
surfac
still
attach
maintain
stabil
due
proxim
unbound
thiol
simpli
reattach
reform
stabilis
np
construct
figur
monothiol
ligand
prone
ligand
exchang
surfac
metal
np
coat
therefor
rapidli
lost
biolog
environ
contrast
bident
dithiol
ligand
offer
increas
stabil
two
simultan
exchang
event
requir
order
disrupt
coat
altern
hexahistidin
ligand
offer
strong
stabl
metal
bind
altern
approach
particularli
wide
employ
functionalis
qd
surfac
utilis
polyhistidin
sequenc
abl
form
multident
np
interact
abil
histidin
residu
bind
varieti
metal
well
establish
throughout
biolog
hexahistidin
motif
particular
found
form
stabl
metal
coordin
figur
hexahistidin
tag
peptid
protein
therefor
wide
use
provid
stabl
biomolecul
aunp
qd
coat
resist
desorpt
wide
varieti
applic
discuss
np
use
biomed
applic
vital
particl
abl
reach
necessari
site
actionth
abil
np
fulfil
specifi
purpos
suffici
particularli
true
particl
deliv
system
rather
appli
directli
desir
site
action
even
particl
overcom
signific
challeng
avoid
rapid
clearanc
bodi
place
formid
barrier
way
subsequ
distribut
deliveri
np
tissu
cellular
level
restrict
bodi
way
protect
maintain
homeostasi
prevent
uncontrol
transport
materi
sensit
environ
penetr
barrier
remain
one
biggest
challeng
biomedicin
small
molecul
therapeut
np
focu
review
decor
particl
peptid
protein
abl
mediat
transport
penetr
forefront
effort
enabl
np
technolog
reach
area
need
perform
function
section
discuss
barrier
turn
give
critic
overview
key
sequenc
utilis
modul
np
transport
across
tabl
tabl
cell
membran
select
permeabl
barrier
effici
protect
cell
interior
environ
specif
small
molecul
may
effici
transport
across
membran
howev
transfer
np
intracellular
space
far
challeng
although
case
uptak
unfunctionalis
particl
possibl
cell
membran
imperm
often
result
highli
detriment
lack
activ
furthermor
even
np
taken
cell
exampl
via
endocytosi
challeng
overup
particl
may
sequest
cytosol
nucleu
endosom
organel
depend
exact
properti
target
cell
type
uptak
mechan
therefor
press
need
develop
np
construct
direct
desir
siteofact
order
maintain
function
recent
year
decor
np
surfac
peptid
abl
promot
uptak
come
promin
mani
socal
cellpenetr
peptid
cpp
sequenc
abl
trigger
receptormedi
endocytosi
studi
detail
furthermor
sequenc
abl
effici
promot
endosom
escap
follow
internalis
also
identifi
use
great
effect
first
briefli
discuss
key
mechan
peptidemedi
np
uptak
highlight
main
sequenc
wide
utilis
biomed
applic
word
caution
import
note
efficaci
penetr
subsequ
endosom
escap
highli
depend
experiment
condit
particular
sequenc
may
success
mediat
transport
one
np
cargo
may
fail
enabl
penetr
anoth
similarli
uptak
may
effici
cell
line
vitro
result
may
readili
replic
correspond
tissu
upon
vivo
translat
therefor
paramount
test
characteris
newli
design
npcpp
construct
biolog
relev
condit
rather
reli
literatur
preced
transport
relat
essenti
distinct
np
cargo
gener
penetr
mechan
split
two
major
categori
direct
energyindepend
pathway
ii
reli
activ
uptak
via
endocytosi
figur
often
multipl
uptak
pathway
exploit
parallel
exact
environment
condit
determin
process
domin
prove
complic
deduc
exact
mechan
internalis
conflict
report
therefor
commonplac
direct
uptak
mechan
typic
initi
interact
peptidenp
conjug
cell
membran
commonli
via
electrostat
interact
posit
charg
surfac
neg
charg
phospholipid
follow
perman
transient
destabil
cell
membran
exampl
pore
invert
micel
format
although
mani
cpp
first
thought
uptaken
via
mean
subsequ
report
demonstr
experiment
artefact
fact
led
initi
discrep
longer
thought
direct
uptak
major
contribut
factor
penetr
cppcoat
np
contrast
endocytot
uptak
interact
cell
membran
compon
lead
engulf
peptidenp
construct
transport
intracellularli
endosom
endocytosi
occur
predominantli
via
macropinocytosi
clathrinor
caveolindepend
receptormedi
uptak
case
subsequ
escap
cargo
result
endosom
locat
key
step
describ
subsequ
section
exact
mechan
particular
np
internalis
vast
area
research
one
often
remain
contenti
exact
detail
therefor
outsid
scope
review
reader
instead
direct
number
excel
review
topic
becom
increasingli
evid
difficult
draw
generalis
importantli
precis
mean
particular
construct
taken
highli
depend
peptid
sequenc
use
promot
uptak
also
target
cell
type
perhap
strongli
exact
natur
np
cargo
includ
size
structur
surfac
properti
specif
biolog
interact
rather
densiti
distribut
posit
charg
along
peptid
backbon
respons
internalis
importantli
despit
abil
cation
peptid
increas
uptak
effici
cytosol
deliveri
np
cargo
often
remain
low
strong
affin
posit
charg
peptid
toward
neg
charg
endosom
membran
compon
may
hinder
endosom
escap
result
addit
factor
abl
mediat
process
may
need
incorpor
np
design
discuss
section
case
note
low
specif
cpp
particular
cell
type
target
organ
lead
widespread
tissu
deliveri
cpp
cross
cell
membran
larg
indiscrimin
manner
lead
uptak
np
almost
cell
encount
technolog
reli
sequenc
often
associ
signific
sideeffect
particularli
use
deliv
therapeut
payload
order
address
limit
number
method
cpp
screen
report
enabl
np
target
prior
unmask
penetr
sequenc
import
earli
demonstr
principl
tsien
group
attach
complementari
polyanion
peptid
abl
electrostat
bind
thu
block
activ
polyarginin
cpp
via
matrix
metalloproteinas
mmp
cleavabl
linker
region
presenc
correspond
proteas
typic
upregul
within
tumour
environ
peptid
cleavag
result
unmask
cation
cpp
intracellular
payload
deliveri
system
subsequ
utilis
intracellular
deliveri
qd
recent
select
vivo
deliveri
pegpolycaprolacton
pcl
np
tumour
figur
relat
approach
screen
activ
cpp
use
steric
bulk
harri
et
al
report
coat
tatfunctionalis
iron
oxid
np
shield
peg
via
cleavabl
peptid
linker
upon
action
proteas
within
tumour
environ
tat
peptid
unmask
enabl
cell
uptak
altern
ultraviolet
uv
lightcleav
group
use
trigger
cleavag
append
lipid
spatial
precis
final
hydrazonelink
peg
cleav
mildli
acid
tumour
environ
also
report
select
unblock
tat
peptid
desir
siteofact
importantli
hydrazon
structur
shown
play
vital
role
rate
hydrolysi
thu
abil
np
construct
undergo
acidmedi
cleavag
suitabl
choic
coupl
partner
hydrazon
halflif
tune
matter
minut
way
month
neutral
ph
therefor
repres
import
consider
construct
design
exampl
aliphat
hydrazon
may
display
insuffici
stabil
allow
applic
vivo
diaryl
linkag
may
prove
stabl
allow
acid
respons
behaviour
display
role
peptideprotein
densiti
densiti
cpp
surfac
coverag
import
determin
np
behaviour
suffici
ligand
must
present
enabl
effici
penetr
also
avoid
overcrowd
diminish
bioactiv
prevent
present
dualfunction
earli
zhao
et
al
demonstr
effici
mnp
uptak
highli
depend
number
conjug
tat
peptid
penetr
greatli
enhanc
peptid
display
particl
surfac
nonlinear
respons
suggest
multival
interact
least
partial
respons
increas
effici
valid
number
subsequ
reportsa
lower
coverag
peptid
bear
multipl
cpp
arm
often
result
higher
cell
uptak
observ
particl
coat
high
densiti
monoval
peptid
though
effect
univers
inde
recent
report
breger
et
al
demonstr
qd
decor
singl
ligand
could
effici
uptaken
multival
dendrimer
cpp
present
number
hypothes
made
explain
origin
effect
often
case
exact
answer
probabl
depend
precis
cell
type
np
cargo
construct
design
receptor
cluster
crosslink
known
play
major
role
mani
cellsurfac
recognit
event
may
also
import
mediat
cell
uptak
increas
membran
curvatur
pore
format
result
greater
localis
electrostat
bind
also
propos
play
role
intriguingli
jana
group
recent
demonstr
valenc
key
determin
uptak
mechan
also
subsequ
subcellular
locat
inde
rate
particl
subsequ
eject
exocytosi
high
valenc
tat
peptid
surfac
qd
found
lead
increas
rate
initi
cell
uptak
howev
particl
rapidli
process
exocytos
lead
overal
drop
penetr
effici
describ
endocytosi
np
without
peptid
functionalis
lead
internalis
within
endosom
unless
tissu
imag
purpos
locat
typic
end
target
deliveri
cytosol
nucleu
usual
necessari
activ
endosom
escap
np
cargo
essenti
yet
often
overlook
factor
enabl
function
number
small
molecul
addit
chloroquin
may
act
transduct
enhanc
use
plausibl
solut
cell
penetr
vivo
altern
number
peptid
sequenc
identifi
abl
promot
escap
typic
format
disrupt
trigger
select
within
acid
environ
endosom
compart
ntermin
domain
influenza
viru
hemagglutinin
one
earliest
sequenc
identifi
plank
et
al
demonstr
functionalis
dnabas
np
greatli
enhanc
cell
transduct
sequenc
oligom
tetrapeptid
gala
penetr
acceler
sequenc
pa
also
utilis
promot
endosom
escap
functionalis
liposom
qd
respect
altern
approach
enhanc
escap
recent
report
morsh
cowork
attach
tat
peptid
aunp
via
acid
labil
hydrazon
linkag
abl
promot
endosom
escap
cleavag
cpp
use
noncleav
linkag
result
strong
bind
peptid
neg
charg
endosom
membran
retain
thu
hinder
particl
escap
bloodbrain
barrier
bbb
formid
restrict
obstacl
abl
exclud
small
molecul
drug
almost
nanoscal
object
order
maintain
brain
homeostasi
endotheli
cell
brain
capillari
form
continu
tight
junction
preclud
paracellular
transport
possibl
disrupt
barrier
allow
passag
cell
commonli
strategi
aim
overcom
bbb
reli
transport
cell
make
barrier
figur
howev
downregul
receptor
mediat
vesicular
transport
presenc
highli
activ
efflux
pump
make
even
transcellular
movement
difficult
four
main
strategi
exploit
order
allow
bbb
penetr
exploit
peptid
protein
decor
np
receptormedi
transport
wherebi
np
interact
overexpress
receptor
bbb
trigger
internalis
ii
transportermedi
movement
hijack
natur
uptak
nutrient
glutathion
brain
iii
adsorpt
transport
result
strong
bind
posit
charg
particl
neg
charg
bbb
iv
exploit
cpp
also
demonstr
mediat
transport
across
bbb
figur
depth
discuss
process
mechan
np
transport
across
bbb
reader
refer
excel
recent
overview
group
gao
tosi
importantli
leaki
bbb
often
increas
pathogenesi
particularli
true
tumour
origin
brain
commonli
refer
glioma
glioma
therefor
commonli
use
model
system
demonstr
abil
particular
np
construct
penetr
bbb
problemat
import
mind
possibl
effect
impair
cellular
junction
np
transport
system
key
cpp
sequenc
utilis
vivo
deliveri
np
outlin
section
also
utilis
deliv
np
cargo
across
bbb
abil
penetr
cell
brain
endothelium
enabl
transcellular
transport
brain
tissu
qd
peptid
selfassembl
aunp
shown
penetr
brain
follow
tat
functionalis
similarli
deliveri
polyargininefunctionalis
liposom
penetratinlabel
pegpla
particl
also
report
howev
describ
promiscu
cpp
limit
specif
brain
target
report
also
associ
system
deliveri
organ
tissu
result
strategi
improv
specif
brain
target
repres
attract
solut
common
techniqu
promot
bbb
specif
transport
target
receptor
bloodbrain
interfac
abl
induc
receptormedi
endocytosi
transferrinreceptor
tfr
overexpress
brain
endotheli
cell
play
crucial
role
transport
iron
across
bbb
mediat
endocytosi
transport
ironbind
protein
transferrin
tf
attach
tf
np
therefor
wide
use
mean
mediat
bbb
penetr
transport
rang
structur
includ
drugload
serum
albumin
np
liposom
polymersom
polym
dendrim
particl
well
rnabas
structur
altern
antitfr
antibodi
utilis
mediat
transport
howev
possibl
difficulti
speciesspecif
antibodi
may
partial
hinder
technolog
exampl
sinc
target
rat
tfr
np
coat
antibodi
unabl
readili
translat
human
system
use
tfr
target
bbb
penetr
signific
limit
spite
attract
target
firstli
tfr
commonli
express
surfac
mani
tissu
particular
liver
spleen
lower
organ
specif
secondli
significantli
due
import
transport
iron
area
bodi
physiolog
level
tf
circul
blood
high
lead
virtual
satur
tfr
prevent
bind
exogen
protein
greatli
limit
abil
tflabel
np
cross
bbb
receptor
close
relat
ironbind
protein
lactoferrin
lf
also
commonli
overexpress
bbb
sinc
endogen
circul
level
lf
far
lower
tf
receptor
target
greatli
facilit
result
wide
rang
lfconjug
np
report
demonstr
cross
bbb
altern
solut
high
physiolog
level
circul
tf
offer
lee
et
al
phage
display
abl
identifi
short
peptid
sequenc
capabl
bind
tfr
noncompetit
manner
tf
result
effici
receptor
mediat
endocytosi
instig
even
satur
level
tf
recent
prade
et
al
demonstr
nmethyl
enantio
retroenantio
deriv
peptid
maintain
even
enhanc
abil
transport
np
across
bbb
decreas
suscept
proteas
mediateddegrad
particl
clearanc
figur
work
repres
impress
demonstr
synthet
versatil
peptid
abil
greatli
improv
characterist
np
cargo
short
peptid
glutathion
gsh
repres
two
promis
candid
clinic
translat
bbbpenetr
np
technolog
peptid
abil
target
intern
receptor
overexpress
brain
endothelium
specif
lowdens
lipoprotein
receptorrel
protein
lrp
gsh
receptor
respect
two
peptid
sequenc
wide
studi
abil
mediat
transport
importantli
display
extrem
low
associ
toxic
therefor
key
compon
number
technolog
current
clinic
trial
first
identifi
demeul
et
al
lrp
bind
kunitz
domain
number
protein
abl
cross
bbb
subsequ
year
utilis
deliv
wide
rang
np
cargo
across
bbb
includ
liposom
polym
upconvert
goldnp
figur
similarli
gsh
decor
use
extens
deliv
np
particularli
drugload
liposom
across
bbb
inde
technolog
base
system
deliveri
doxorubicin
glioma
recent
complet
phase
iiia
clinic
trial
use
tradenam
formul
son
addit
promin
exampl
number
peptid
sequenc
identifi
abl
mediat
transport
across
bbb
mani
deriv
pathogen
toxin
mimick
abil
parent
proteinpeptid
elicit
damag
within
brain
either
disrupt
endotheli
membran
receptormedi
endocytosi
snake
venombas
peptid
cdx
chlorotoxin
bee
venomderiv
opioid
glycopeptid
rabi
virusderiv
peptid
shown
enabl
deliveri
np
cargo
across
bbb
final
attach
cation
protein
also
prove
effect
method
promot
np
transport
particular
cation
serum
albumin
protein
subsequ
np
decor
shown
promot
bbb
penetr
initi
bind
induc
electrostat
interact
highli
neg
charg
brain
endothelium
follow
subsequ
adsorptivemedi
transcytosi
structur
function
abnorm
tumour
tissu
offer
mani
opportun
np
deliveri
penetr
also
mani
challeng
must
overcom
earli
studi
rodent
suggest
endotheli
barrier
line
vasculatur
display
increas
permeabl
larg
speci
reduc
lymphat
drainag
enhanc
tumour
retent
two
factor
combin
form
basi
enhanc
permeabl
retent
epr
effect
howev
impact
epr
effect
nanomedicin
remain
highli
controversi
studi
extens
rodent
clinic
relev
epr
effect
human
patient
remain
uncertain
even
within
singl
model
speci
poros
vasculatur
vari
dramat
depend
tumour
type
growth
stage
microenviron
even
individu
furthermor
even
accumul
subsequ
transport
particl
across
bloodtumour
barrier
penetr
poorli
vascularis
hypox
environ
dens
cellularis
solid
tumour
remain
problemat
number
peptid
sequenc
identifi
abl
first
target
np
tumour
site
also
lead
distribut
across
entir
mass
amongst
cend
rule
cendr
class
peptid
identifi
pioneer
ruoslahti
group
particularli
promin
cendr
peptid
first
isol
phage
display
librari
teesalu
et
al
screen
peptid
cancer
cell
abl
identifi
consensu
rk
xx
rk
sequenc
promot
cell
uptak
sequenc
share
homolog
bind
domain
vascular
endotheli
growth
factor
vegf
cendr
peptid
thought
compet
uptak
importantli
motif
must
present
cterminu
peptid
order
caus
penetr
henc
name
cendr
intern
revers
sequenc
biolog
effect
importantli
requir
cendr
sequenc
place
peptid
cterminu
enabl
use
cryptic
intern
sequenc
block
proteasesensit
direct
motif
specif
deliveri
target
tissu
exploit
sugahara
et
al
produc
peptid
irgd
abl
target
varieti
np
substrat
promot
uptak
proteas
process
achiev
multistep
mechan
bind
first
induc
interact
termin
rgd
motif
integrin
overexpress
surfac
mani
tumour
see
section
target
moieti
proteolyt
cleav
expos
cendr
peptid
induc
cell
penetr
follow
interact
combin
rgd
target
cendr
penetr
motif
within
singl
modular
peptid
construct
enabl
greatli
enhanc
tumour
penetr
lipid
micel
iron
oxid
nanoworm
albumin
np
compar
particl
bear
either
motif
isol
figur
irgd
np
decor
subsequ
utilis
deliv
polyethylenimin
pei
peg
np
gene
therapi
glioblastoma
iron
oxid
imag
agent
detect
breast
cancer
metastasi
doxorubicin
coat
aunp
deep
tumour
site
discuss
section
number
peptid
sequenc
target
np
cancer
region
identifi
use
home
particl
desir
site
sequenc
often
mere
lead
np
distribut
peripheri
tumour
vasculatur
rather
activ
enabl
penetr
deeper
tissu
howev
smaller
number
peptid
sequenc
identifi
abl
promot
process
first
target
np
deliveri
tumour
penetr
away
vasculatur
via
receptor
mediat
transcytosi
one
peptid
sequenc
truncat
deriv
inflammatori
cytokin
promiscu
receptor
activ
profil
throughout
bodi
yet
found
select
receptor
strongli
overexpress
surfac
mani
tumour
cell
thu
repres
interest
target
tumourdirect
therapi
addit
provid
receptor
specif
overcom
low
stabil
high
immunogen
parent
protein
furthermor
found
subsequ
promot
cell
tumour
penetr
make
effect
tool
np
deliveri
seri
paper
gao
cowork
demonstr
decor
pegpcl
np
could
use
effici
deliv
anticanc
therapeut
suppress
glioma
growth
vivo
wang
et
al
also
demonstr
target
phagedisplay
deriv
bind
peptid
enabl
glioma
target
penetr
allow
deliveri
poli
lacticcoglycol
acid
plga
peg
np
similar
manner
cyclic
peptid
first
identifi
phagedisplay
librari
laakkonen
et
al
tumourhom
peptid
target
overexpress
receptor
karmali
et
al
demonstr
deliveri
clinic
approv
paclitaxel
np
deliveri
vehicl
could
significantli
improv
decor
subsequ
investig
develop
peptid
combin
cryptic
cendr
motif
greatli
increas
cell
penetr
well
distribut
throughout
tumour
mass
thu
increas
efficaci
therapeut
deliveri
direct
np
construct
organ
tissu
action
requir
crucial
ensur
success
function
therapeut
diagnost
tool
abil
peptid
protein
coat
modul
distribut
within
bodi
wide
exploit
combin
motif
reduc
clearanc
reticuloendotheli
system
success
deliv
particl
intracellularli
target
deliveri
lead
highli
potent
nanotechnolog
target
approach
broadli
classifi
two
mode
passiv
activ
though
name
mislead
impli
ration
target
particl
design
rather
natur
distribut
activ
guid
target
site
rather
localis
chanc
encount
respect
passiv
target
exploit
normal
np
biodistribut
typifi
observ
accumul
particl
vasculatur
tumour
via
epr
effect
discuss
may
also
enabl
target
liver
spleen
np
natur
deposit
follow
clearanc
blood
organ
tissu
requir
sophist
activ
mean
direct
deliveri
commonli
achiev
introduct
recognit
motif
around
corona
np
preferenti
bind
cellsurfac
receptor
biomolecul
expos
within
target
area
small
molecul
vitamin
carbohydr
peptid
protein
aptam
utilis
target
deliveri
section
discuss
common
polypeptid
sequenc
utilis
direct
np
transport
impact
biomed
technolog
short
peptid
emerg
prefer
agent
influenc
np
distribut
due
number
advantag
properti
tabl
firstli
compar
full
size
protein
target
agent
peptid
abl
form
compact
np
coat
due
small
size
limit
disrupt
np
hydrodynam
diamet
furthermor
surfac
load
control
enabl
simultan
present
multipl
target
sequenc
provid
high
affin
synergist
bind
peptid
less
amino
acid
also
access
straightforward
manner
via
solidphas
peptid
synthesi
enabl
facil
introduct
function
chemic
handl
nonnatur
residu
may
provid
eas
conjug
sequenc
increas
bind
thu
target
effici
final
peptid
offer
possibl
lower
immunogen
increas
stabil
present
reduc
bind
physiolog
biomolecul
compar
full
length
protein
mani
peptidetarget
ligand
utilis
biomed
applic
first
identifi
phage
display
pan
experi
target
tissu
receptor
cell
type
first
report
smith
phage
display
reli
present
short
amino
acid
sequenc
protein
coat
filament
phage
random
peptid
librari
defin
length
express
screen
bind
target
follow
sever
round
increasingli
stringent
screen
coupl
amplif
bind
phage
peptid
high
target
affin
identifi
phage
display
wide
use
screen
bind
target
protein
cellsurfac
receptor
howev
also
possibl
system
deliv
phage
librari
vivo
use
techniqu
phage
bind
target
tissu
organ
isol
peptid
sequenc
mediat
cargo
transport
desir
locat
identifi
ruoslahti
group
utilis
vivo
biopan
identifi
number
sequenc
abl
target
np
deliveri
particularli
cancer
tissu
et
al
demonstr
sequenc
gfe
target
membran
dipeptidas
endotheli
cell
lung
vasculatur
bind
blood
vessel
variou
tumour
cell
type
target
tumour
lymphat
vessel
discuss
section
could
use
select
deliv
qd
vivo
interestingli
label
particl
use
multiplex
imag
blood
lymphat
vessel
within
tumour
figur
exquisit
sensit
target
specif
offer
sequenc
part
due
multival
present
qd
surfac
highlight
power
combin
peptid
display
nanomateri
biomed
imag
similar
manner
tumourhom
pentapeptid
creka
also
identifi
phage
librari
found
target
clot
plasma
protein
accumul
within
interstiti
tissu
vessel
wall
cancer
mass
figur
peptid
abl
deliv
iron
oxid
np
liposom
desir
site
observ
induc
addit
clot
thu
amplifi
accumul
poor
perfus
tumour
vasculatur
shown
limit
penetr
np
tumour
tissu
present
major
obstacl
effect
tumour
treatment
section
introduc
number
sequenc
address
difficulti
mediat
transcellular
transport
deep
tumour
mass
peptid
describ
one
sequenc
play
dualfunct
role
mediat
target
penetr
discuss
section
karmali
et
al
demonstr
combin
creka
peptid
sequenc
within
singl
np
construct
enabl
target
deliveri
tumour
penetr
paclitaxel
contain
particl
accumul
tumour
penetr
greatli
enhanc
peptid
present
compar
np
functionalis
singl
speci
demonstr
abil
creka
act
synergist
fashion
minimis
tumour
growth
phagedisplay
deriv
cendr
famili
peptid
introduc
section
tumourpenetr
sequenc
also
combin
target
motif
provid
dualfunct
linear
peptid
inde
discuss
previous
intern
irgd
sequenc
make
use
one
wide
studi
utilis
target
group
rgd
direct
cargo
cell
overexpress
integrin
irgd
coat
np
shown
effici
vehicl
drugdeliveri
imag
applic
contrast
rgd
peptid
lack
proteolyt
site
requir
expos
cendr
sequenc
enabl
penetr
deep
tumour
tissu
vivo
despit
abil
instig
tumour
deliveri
number
peptid
sequenc
abl
target
np
tumour
tissu
identifi
includ
cyclicand
linearngr
bind
tumour
vasculatur
receptor
mani
peptid
identifi
target
wide
rang
tumour
type
sequenc
also
exist
direct
particl
specif
cancer
bind
overexpress
tissuespecif
receptor
exampl
bladder
cancer
bind
peptid
identifi
whole
cell
phagepan
lee
et
al
peptid
subsequ
shown
mediat
direct
deliveri
doxorubicinload
msnp
treatment
bladder
cancer
similarli
peptid
abl
bind
human
epiderm
growth
factor
utilis
select
deliv
np
breast
cancer
tissu
mimick
activ
antibodi
use
number
clinic
breast
cancer
treatment
addit
imag
therapeut
nppeptid
conjug
develop
specif
target
prostat
cancer
predominantli
use
sequenc
identifi
biopan
cancer
cell
vivo
although
peptid
target
tumour
wide
studi
sequenc
specif
healthi
tissu
also
identifi
use
deliv
np
cargo
adipos
tissu
particularli
wide
target
consequ
import
role
obes
relat
patholog
kolonin
et
al
first
identifi
white
fat
direct
peptid
ckggrakdc
phagedisplay
librari
demonstr
abil
carri
proapoptot
peptid
revers
obes
figur
hossen
et
al
subsequ
demonstr
deliveri
drugload
pegyl
np
control
adipos
behaviour
weight
gain
peptid
also
report
mediat
deliveri
proangiogen
agent
abl
stimul
convers
brown
adipos
tissu
readili
expend
normal
energi
usag
heart
brain
major
organ
interest
deliveri
np
therapeut
diagnost
purpos
follow
myocardi
infarct
leaki
blood
vessel
left
ventricl
promot
passiv
np
accumul
particl
also
select
deliv
target
angiotensin
ii
type
receptor
commonli
overexpress
infarct
tissu
dvir
et
al
demonstr
truncat
amino
acid
peptid
mimick
behaviour
angiotensin
ii
thu
abl
direct
deliveri
therapeut
liposom
altern
nguyen
et
al
report
overexpress
mmp
within
heart
follow
infarct
could
use
direct
aggreg
drugload
np
follow
proteolyt
degrad
hydrophil
surfac
peptid
thu
accumul
infarct
site
order
mediat
np
deliveri
brain
mann
et
al
recent
develop
short
tetrapeptid
caqk
despit
rel
short
length
remark
abl
target
deliveri
small
molecul
np
cargo
importantli
peptid
display
affin
extravascular
tissu
rather
blood
vessel
result
deliveri
enabl
throughout
site
acut
brain
injuri
distribut
therapeut
payload
addit
peptid
direct
deliveri
particl
certain
part
bodi
sever
sequenc
abl
drive
np
accumul
within
specif
subcellular
locat
follow
cell
uptak
also
identifi
distinct
peptid
induc
cell
penetr
endosom
escap
sequenc
enabl
intracellular
traffick
site
action
requir
although
sequenc
commonli
utilis
vitro
studi
target
intracellular
process
recent
studi
also
demonstr
applic
biomed
set
agemi
et
al
combin
mitochondri
target
peptid
klaklak
tumourtarget
cgkrk
penetr
irgd
sequenc
form
trifunct
iron
oxid
np
coat
abl
effici
deliv
particl
within
mous
glioblastoma
model
addit
target
role
klaklak
also
promot
apoptosi
disrupt
mitochondri
membran
increas
therapeut
effect
anoth
exampl
endoplasm
reticulum
er
retent
signal
eriss
deriv
adenoviru
protein
use
direct
np
er
lymphocyt
improv
process
present
npdisplay
antigen
effici
synthet
vaccin
greatli
enhanc
vivo
discuss
section
lead
improv
gener
immun
recognit
protein
bind
partner
cellsurfac
receptor
one
import
interact
biolog
vast
number
hormon
growth
factor
cytokin
cell
adhes
protein
cellsignal
structur
involv
virtual
intracellular
interact
enabl
format
function
complex
tissu
therefor
surpris
proteinnp
coat
becom
import
mean
drive
target
deliveri
certain
area
bodi
particular
receptor
like
overexpress
tabl
describ
section
ironbind
protein
tf
lf
mediat
transport
key
nutrient
around
bodi
np
coat
structur
therefor
target
site
relev
receptor
express
epitomis
abil
deliv
particl
inde
induc
transport
across
bbb
tfr
particularli
widespread
distribut
throughout
bodyalmost
cell
thought
express
cell
surfac
tfr
albeit
significantli
vari
level
howev
overexpress
tfr
certain
cancer
result
rapid
cell
growth
kinet
thu
demand
need
iron
enabl
use
tf
target
agent
combin
potenti
particl
accumul
within
tumour
vasculatur
via
epr
effect
interestingli
number
paper
demonstr
tfr
target
occur
result
alter
biodistribut
similar
accumul
kinet
observ
functionalis
nonfunctionalis
np
instead
abil
target
group
induc
penetr
uptak
within
target
tissu
lead
enhanc
therapeut
effici
np
drugdeliveri
vehicl
degre
tf
modif
play
import
role
determin
level
np
uptak
whether
multival
interact
increas
chanc
recognit
salvati
et
al
also
highlight
import
care
design
np
coat
order
maintain
maxim
activ
vivo
follow
incub
tffunctionalis
silica
np
serum
show
rapid
loss
tfr
target
occur
due
accumul
block
protein
corona
despit
sensit
tf
functionalis
wide
utilis
strategi
direct
tumour
deliveri
system
shown
mediat
transport
wide
rang
np
cargo
well
core
sever
liposom
base
therapeut
technolog
current
clinic
trial
figur
mani
protein
ligand
also
found
widespread
use
select
target
np
cell
surfac
receptor
within
specif
tissu
organ
import
consider
abil
mani
ligand
trigger
cellular
respons
downstream
effect
may
favour
certain
applic
case
protein
substrat
mere
act
target
motif
also
control
induc
biolog
effect
exampl
growth
factor
epiderm
growth
factor
egf
vegf
use
target
np
relev
receptor
overexpress
surfac
tumour
cell
tissu
howev
potenc
growth
factor
cell
signal
moieti
often
promiscu
activ
profil
must
care
control
particularli
follow
system
deliveri
furthermor
cellsurfac
adhes
motif
also
target
chen
et
al
demonstr
iron
oxid
np
could
functionalis
lymphocyt
functionassoci
antigen
lfa
protein
abl
target
intercellular
adhes
surfac
tumour
cell
inflam
tissu
vivo
high
densiti
lipoprotein
hdlp
also
found
util
select
np
deliveri
lipidprotein
hybrid
natur
form
spheric
particl
order
mediat
transport
lipid
around
bodi
interact
hdlp
number
receptor
commonli
implic
patholog
condit
exploit
deliv
np
base
therapeut
agent
imag
tool
scaveng
receptor
type
wide
target
exampl
yang
et
al
demonstr
aunp
templat
hdlp
particl
could
use
select
sequest
cholesterol
vivo
figur
structur
could
target
bcell
lymphoma
cell
due
need
cholesterol
thu
upregul
express
similarli
apolipoprotein
ai
major
compon
hdlp
demonstr
enabl
select
deliveri
fluoresc
np
cancer
tissu
vivo
although
cell
surfac
receptor
commonli
utilis
target
np
deliveri
cell
tissu
specif
marker
also
utilis
mediat
np
target
promin
lectin
carbohydratebind
protein
direct
np
tissu
display
particular
cellsurfac
glycan
glycoprotein
glycolipid
play
vital
role
cell
biolog
provid
stabil
cell
membran
facilit
cellular
recognit
ad
extra
level
complex
function
protein
determin
cell
behaviour
rapidli
improv
tool
studi
role
glycan
mani
normal
diseas
state
biolog
import
increasingli
appreci
result
specif
glycoform
identifi
promin
display
certain
patholog
make
attract
target
np
deliveri
lectin
commonli
display
exquisit
sensit
particular
sugar
structur
conform
often
analog
shown
antibodi
wheat
germ
agglutinin
wga
bind
specif
nacetylglucosamin
residu
commonli
found
alveolar
epithelium
thu
utilis
surti
misra
deliv
corticosteroid
load
np
lung
tissu
number
group
subsequ
use
wga
induc
intranas
transport
functionalis
np
due
abil
bind
promot
transcellular
deliveri
across
epitheli
barrier
nasal
passageway
ulex
europaeu
agglutinin
also
use
select
bind
residu
surfac
microfold
cell
mcell
within
small
intestin
oral
deliveri
label
antigen
contain
np
enabl
initi
mucos
immun
respons
vaccin
recipi
mucos
mcell
also
target
via
intranas
deliveri
provid
facil
mean
undertak
needlefre
np
immun
abil
antibodi
ab
bind
high
specif
affin
target
antigen
make
ideal
direct
group
deliveri
np
cargo
therefor
unsurpris
abnp
conjug
found
widespread
util
biomed
field
abil
ab
neutralis
effect
target
induc
favour
biolog
respons
allow
use
therapeut
agent
right
also
commonli
exploit
deliv
therapeut
cargo
form
abdrug
conjug
adc
start
monoclon
ab
technolog
clinic
trial
await
grant
market
approv
import
tumour
deliveri
highlight
fact
system
target
toward
cancer
therapi
gener
ab
target
protein
cell
type
tissu
interest
outsid
scope
review
reader
direct
instead
number
comprehens
review
detail
ab
compos
chain
light
heavi
constant
variabl
region
specif
toward
desir
target
gener
predominantli
variabl
region
ab
fragment
may
therefor
retain
bind
affin
full
length
construct
though
case
bisantigen
bind
necessari
maintain
full
affin
smaller
target
group
produc
via
genet
engin
care
proteasemedi
ab
digest
gener
motif
overcom
disrupt
size
potenti
immunogen
high
cost
parent
ab
full
length
fragment
ab
extens
use
target
deliveri
np
cargo
natur
occur
singl
domain
camelid
ab
tumour
particularli
wide
target
due
frequenc
cellsurfac
receptor
overexpress
thu
use
site
select
deliveri
common
realis
abnp
strategi
deliv
therapeut
payload
via
liposom
drugdeliveri
vehicl
though
np
format
therapeut
diagnost
purpos
also
subject
signific
interest
overexpress
implic
breast
cancer
thu
repres
import
target
deliveri
select
ab
trastuzumab
sold
tradenam
herceptin
relat
structur
probabl
wide
studi
utilis
target
group
np
deliveri
seri
earli
paper
park
cowork
demonstr
label
liposom
ab
result
effici
deliveri
vehicl
target
breast
cancer
xenograft
chemotherapeut
dna
target
iron
oxid
np
also
wide
report
mean
induc
direct
hyperthermia
mri
imag
figur
ndong
et
al
recent
report
singl
antigenbind
fragment
trastuzumab
could
also
use
target
vivo
lead
effect
deliveri
iron
oxid
particl
tumour
site
epiderm
growth
factor
receptor
egfr
anoth
popular
target
abmedi
deliveri
egfr
overexpress
implic
mani
cancer
especi
epitheli
origin
thu
serv
use
target
immunoliposom
target
inde
singl
antigenbind
fragment
monoclon
ab
cetuximab
conjug
doxorubicin
load
liposom
test
phase
clinic
trial
treatment
patient
solid
malign
choic
ab
use
full
length
protein
fragment
np
cargo
import
consider
design
ablabel
technolog
howev
widespread
interest
abnp
conjug
led
identif
number
key
design
criteria
orient
ab
np
surfac
import
considerationnonspecif
protein
modif
techniqu
lead
ab
conjug
mani
differ
np
bind
point
may
result
antigenbind
domain
posit
hinder
block
orient
inde
recent
studi
herda
et
al
demonstr
littl
graft
protein
possess
access
epitop
follow
nonspecif
conjug
silica
np
use
sitespecif
modif
strategi
abl
select
form
abnp
conjug
away
activ
recognit
site
like
improv
effici
np
target
vivo
extent
green
et
al
recent
report
strategi
function
rebridg
distal
disulphid
bond
within
trastuzumab
fragmentab
enabl
orient
ab
display
surfac
plgapeg
np
correspond
increas
bind
effici
compar
nonspecif
ab
conjug
relat
manner
ab
load
densiti
np
surfac
play
import
role
target
effici
high
level
hinder
antigenbind
may
result
lead
initi
counterintuit
drop
target
effici
inde
jiang
et
al
demonstr
size
np
templat
play
import
role
determin
hindranc
thu
bind
effici
increas
curvatur
lead
increas
separ
thu
decreas
steric
inhibit
antigen
recognit
although
multival
ab
display
may
desir
case
order
promot
receptor
recognit
recent
paper
group
davi
prosperi
highlight
may
alway
case
case
singli
ab
label
np
found
suffici
case
colombo
et
al
superior
multival
ab
display
effect
tumour
target
mani
biolog
entiti
fall
within
nanometr
size
regim
display
multival
peptid
protein
motif
surfac
nppolypeptid
conjug
abl
effect
mimic
behaviour
structur
stimul
signal
pathway
elicit
cellular
respons
interact
induc
particl
respons
mani
applic
discuss
review
promot
receptor
cluster
often
implic
receptormedi
endocytosi
cell
tissu
penetr
np
target
may
enhanc
multival
interact
nanoscal
topic
alreadi
cover
detail
section
focu
abil
nppolypeptid
construct
mimic
multival
display
antigen
present
surfac
pathogen
tumour
cell
conjug
abl
induc
control
immun
respons
thu
gener
immun
recipi
technolog
reli
encapsul
rather
surfac
present
antigen
outsid
scope
review
reader
instead
direct
number
comprehens
review
topic
furthermor
use
selfassembl
peptidesprotein
np
vaccin
candid
detail
section
also
discuss
detail
np
vaccin
offer
benefit
increas
antigen
stabil
solubl
deliveri
furthermor
nanoscal
size
may
promot
scaveng
dendrit
cell
therefor
improv
tcell
present
minimis
activ
altern
immun
respons
pathway
reddi
et
al
demonstr
np
suffici
small
size
nm
preferenti
drainag
accumul
lymph
node
enabl
howev
report
suggest
particl
diamet
may
also
preferenti
accumul
certain
deliveri
condit
highlight
need
investig
phenomena
preferenti
exploit
lymphat
system
bring
particl
closer
contact
resid
dendrit
cell
lead
enhanc
activ
immun
system
maximis
vaccin
effici
howev
major
advantag
npbase
vaccin
lie
abil
enabl
multival
display
antigen
promot
interact
multipl
ligandreceptor
pair
process
often
play
essenti
role
tcell
activ
rather
reli
individu
recognit
event
present
multipl
antigen
np
surfac
play
far
effect
role
modul
immun
respons
present
free
peptid
protein
motif
interestingli
shown
antigen
pattern
play
crucial
role
activ
result
antigen
graft
key
design
featur
product
np
vaccin
yu
group
demonstr
enhanc
antigen
cluster
elicit
stronger
immun
respons
uniformli
distribut
ligand
micron
nano
scale
similarli
particl
surfac
close
mimic
natur
context
antigen
liposom
abl
mimic
cell
membran
found
improv
activ
effici
amongst
np
use
synthet
vaccin
hard
np
gener
wide
appli
surfac
present
biomimet
peptideprotein
antigen
contrast
soft
particl
abl
encapsul
payload
commonli
utilis
deliveri
antigen
follow
particl
recognit
subsequ
releas
aunp
particular
found
widespread
use
np
antigen
carrier
due
eas
surfac
functionalis
high
surfacearea
biocompat
tunabl
size
importantli
recent
research
suggest
aunp
may
also
act
sizeand
shapedepend
adjuv
stimul
immun
system
enhanc
antigen
recognit
result
attach
peptid
protein
ligand
aunp
emerg
effect
mean
stimul
product
ab
wide
rang
patholog
pathogen
includ
malaria
foot
mouth
diseas
yersinia
pesti
bacteria
respons
plagu
cancer
via
glycoprotein
influenza
viru
streptococcu
pneumonia
respiratori
syncyti
viru
enceph
caus
virus
hiv
via
deriv
peptid
singleand
multiwal
carbon
nanotub
cnt
also
wide
explor
antigen
carrier
due
larg
biolog
inert
natur
facil
surfac
modif
abil
induc
cell
penetr
howev
recent
report
toxic
may
limit
develop
toward
applic
patient
sinc
first
introduc
pantarotto
et
al
peptideand
proteinmodifi
cnt
utilis
gener
immun
respons
rang
antigen
includ
tumour
lysat
plasmodium
vivax
apic
membran
deriv
peptid
mycobacterium
tuberculosi
protein
deriv
wilm
tumour
antigen
foot
mouth
viru
deriv
antigen
hard
np
polystyren
nanobead
polyacryl
dendrim
calcium
phosphat
particl
also
shown
enabl
ab
gener
vivo
baneyx
group
recent
report
calcium
phosphat
bind
peptid
epitop
attach
termini
desir
antigen
induc
biominer
particl
assembl
late
stage
formul
process
low
stabil
calcium
phosphat
particl
mitig
allow
ondemand
product
applic
take
place
although
soft
organ
np
rare
use
formul
vaccin
number
exampl
exist
mani
case
reveal
interest
facet
vaccin
design
care
consid
regardless
particl
type
exampl
liposom
formul
commonli
utilis
encapsul
peptid
protein
antigen
enabl
deliveri
immun
cell
typic
follow
target
deliveri
virosom
liposom
functionalis
viru
compon
often
influenza
viru
deriv
abl
mimic
viral
envelop
particularli
wide
use
safe
selfadjuv
stabl
antigen
deliveri
vehicl
howev
guan
et
al
demonstr
surfacepresent
ligand
within
liposom
formul
abl
mediat
activ
altern
branch
immun
system
vivo
compar
encapsul
antigen
care
np
design
therefor
key
ensur
desir
respons
trigger
similarli
peptidelipid
amphiphil
also
studi
discuss
section
abil
selfassembl
peptidedecor
micel
use
peptid
key
structur
compon
result
extrem
high
densiti
surfac
antigen
coverag
enhanc
recognit
activ
effici
importantli
crowd
environ
provid
setup
found
induc
peptid
adopt
secondari
structur
akin
natur
present
within
parent
protein
result
ab
gener
downstream
better
abl
produc
effect
respons
subsequ
challeng
applic
use
peptideand
proteinnp
conjug
vaccin
stimul
protect
immun
respons
previous
unencount
antigen
wide
studi
technolog
modul
immun
system
particular
mitig
autoimmun
begun
emerg
healthi
individu
toler
selfantigen
maintain
activ
regulatori
cell
treg
modul
treg
activ
address
defici
thu
attract
target
treatment
autoimmun
diseas
tsai
et
al
demonstr
present
recombin
major
histocompat
complex
bear
type
associ
peptid
surfac
iron
oxid
np
result
vivo
expans
treg
ultim
restor
normoglycemia
diabet
mice
furthermor
codeliveri
myelin
peptid
known
target
autoimmun
respons
patient
suffer
multipl
sclerosi
tolerogen
small
molecul
stimul
treg
prolifer
surfac
aunp
subsequ
shown
suppress
symptom
within
mous
model
diseas
recent
hess
et
al
utilis
qd
scaffold
display
myelin
peptid
allow
author
monitor
distribut
activ
pathway
nppeptid
complex
vivo
much
review
focuss
system
peptid
protein
defin
modul
np
function
perform
addit
role
peptideprotein
emerg
key
structur
motif
integr
format
well
eventu
end
applic
np
inde
mani
scenario
discuss
section
particl
compos
entir
peptid
protein
compon
peptid
selfassembl
complex
nanoarchitectur
instig
combin
intraand
intermolecular
noncoval
interact
includ
hydrogen
bond
electrostat
hydrophob
interact
stack
although
individu
interact
may
weak
cumul
abl
defin
secondari
tertiari
structur
complex
nativ
protein
architectur
exploit
produc
vast
array
selfassembl
structur
nanoand
microscal
format
architectur
rang
fibr
tube
vesicl
micel
elabor
structur
crystal
donut
instig
fundament
drive
forc
behind
format
particular
architectur
becom
increasingli
well
understood
mani
case
rout
assembl
remain
dynam
process
affect
seemingli
minor
modif
peptid
primari
structur
growth
condit
format
selfassembl
peptid
architectur
found
widespread
applic
across
biomed
field
afield
wider
materi
research
commun
focu
format
spheric
np
particularli
peptideprotein
micel
vesicl
condit
format
structur
often
strict
requir
precis
control
composit
assembl
condit
handl
depth
overview
wider
field
particular
use
selfassembl
peptid
format
nanofibr
hydrogel
nanotub
reader
refer
excel
recent
review
subject
note
cover
nanos
aggreg
globular
protein
review
form
serum
albumin
gelatin
found
increas
clinic
use
recent
year
system
reli
specif
selfassembl
polypeptid
compon
thu
fall
outsid
scope
review
number
review
focuss
topic
recent
publish
dipeptid
repres
simplest
selfassembl
peptid
motif
sinc
breakthrough
discoveri
rech
gazit
diphenylalanin
assembl
nanotub
high
concentr
widerang
nanoarchitectur
report
make
use
natur
nonnatur
amino
acid
often
presenc
diaromat
motif
vital
provid
drive
forc
assembl
via
stack
eas
dipeptid
access
synthet
make
particularli
attract
structur
biomed
applic
research
divers
background
abl
exploit
use
first
dipeptid
shown
form
spheric
particl
unnatur
structur
diphenylglycin
stark
contrast
nanotub
form
close
relat
diphenylalanin
signific
seemingli
minor
differ
subtl
chang
structur
highlight
surpris
versatil
simpl
structur
situat
complic
dynam
natur
dipeptid
nanostructur
observ
result
revers
transit
architectur
respons
stimuli
incub
condit
despit
appar
plastic
dipeptid
np
exhibit
remark
stabil
inde
diphenylglycin
particl
shown
stabl
acid
base
treatment
observ
chang
particl
number
despit
simplic
dipeptid
assembl
applic
biomedicin
limit
report
earli
exampl
alam
et
al
demonstr
np
could
load
anticanc
drug
curcumin
use
induc
tumour
regress
mous
melanoma
model
importantli
unnatur
amino
acid
dehydrophenylalanin
increas
pack
effici
thu
enhanc
physic
stabil
increas
stack
also
promot
biolog
stabil
provid
proteas
resist
recent
fan
et
al
report
assembl
produc
fluoresc
np
combin
stack
peptidezinc
interact
abl
produc
particl
visibl
light
emiss
mimick
redshift
emiss
exhibit
fluoresc
protein
upon
metalbind
subsequ
modif
particl
surfac
bind
aptam
enabl
biocompt
enhanc
compar
fluoresc
np
quantum
dot
although
promis
system
far
demonstr
vitro
offer
attract
mean
produc
simpl
photost
biocompat
np
vivo
imag
futur
amphiphil
peptid
contain
hydrophob
hydrophil
domain
broadli
split
three
categori
compos
nativ
amino
acid
without
minor
modif
termini
ii
contain
unnatur
amino
acid
iii
lipidor
polymerconjug
peptid
hybrid
three
group
selfassembl
spheric
particl
typic
driven
mixtur
hydrophob
electrostat
interact
format
secondari
structur
possibl
case
format
nanovesicl
compos
entir
nativ
amino
acid
refer
instanc
peptosom
first
report
vauthey
et
al
ctermin
aspart
acid
residu
bear
neg
charg
respect
found
suffici
drive
assembl
ncap
hydrophob
peptid
chain
alanin
valin
leucin
residu
dynam
heterogen
mixtur
nanotub
vesicl
micel
observ
depend
exact
peptid
sequenc
subsequ
report
format
vesicl
glycinetail
anion
peptid
cation
peptid
bear
lysin
histidin
termini
valid
approach
hydrophob
tail
charg
head
group
effect
mimick
structur
lipid
surfact
interestingli
recent
report
rather
form
tailtotail
arrang
analog
observ
lipid
membran
hydrophob
region
amphiphil
peptid
form
interdigit
assembl
lead
greatli
reduc
membran
thick
despit
import
fundament
studi
abil
short
amphiphil
nativepeptid
form
vesicl
biomed
applic
date
limit
rel
instabl
selfassembl
construct
linear
peptid
typic
exhibit
high
critic
aggreg
concentr
cac
aqueou
solut
particl
format
occur
dynam
equilibrium
free
peptid
therefor
often
exist
situat
complic
complex
biolog
fluid
number
differ
approach
taken
address
issu
yet
often
cac
dissoci
constant
report
obscur
analysi
particl
stabil
gudlar
et
al
show
branch
peptid
deriv
natur
transmembran
helic
enhanc
vesicl
stabil
result
enhanc
hydrophob
interact
branch
structur
found
key
drive
forc
preferenti
format
vesicl
fibr
close
mimick
dihydrophob
tail
nativ
lipid
enabl
deliveri
cargo
cell
vitro
order
stabilis
vesicl
postform
van
hell
et
al
incorpor
cystein
residu
primari
structur
amphiphil
peptid
rationallydesign
amphiphil
sequenc
contain
sequenti
hydrophob
residu
decreas
bulk
lead
coneshap
monom
promot
format
spheric
architectur
cac
prior
crosslink
format
interchain
disulphid
linkag
adjac
cystein
led
product
stabl
vesicl
enabl
cellular
deliveri
encapsul
photosensit
altern
approach
stabilis
selfassembl
peptid
architectur
incorpor
nonn
function
simplest
form
involv
incorpor
unnatur
amino
acid
report
tanisaka
et
al
provid
increas
hydrophob
interact
well
resist
proteas
vivo
stabl
vesicl
compos
hydrophil
sarcosin
hydrophob
methyl
glutam
residu
shown
accumul
cancer
tissu
result
epr
effect
anim
xenograft
take
concept
format
lipidor
polymerhybrid
peptid
becom
attract
mean
drive
peptid
selfassembl
liu
et
al
demonstr
addit
cholesterol
end
hydrophil
hexaargininetat
peptid
block
drove
micel
format
cac
structur
abl
preferenti
disrupt
bacteri
cell
membran
thu
act
antimicrobi
agent
vivo
though
import
note
host
haemolysi
like
sideeffect
higher
concentr
similarli
lv
et
al
shown
triblock
pegpolyphenylalaninepolyglutam
acid
polymerpeptid
hybrid
abl
form
stabl
stealth
nanoparticl
deliveri
encapsul
doxorubicin
tumour
cac
upon
glutam
acid
proton
increasingli
acid
environ
matur
endosom
disassembl
subsequ
cargo
releas
led
tumour
apoptosi
extens
use
linear
peptid
amphiphil
higher
order
repetit
branch
peptid
dendrim
increas
bulk
uniqu
globular
architectur
also
found
util
dendrim
typic
interact
suffici
form
stabl
selfassembl
structur
seri
paper
gu
group
develop
eleg
solut
barrier
use
cooper
selfassembl
process
hydrophil
polylysin
dendrim
first
electrostat
bound
linear
hydrophob
peptid
bear
neg
charg
ctermin
glutam
residu
amphiphil
supramolecular
dendrim
selfassembl
nanos
micel
capabl
encapsul
hydrophob
drug
dna
cargo
weakli
acid
endosom
condit
follow
uptak
glutam
proton
lead
disassembl
nanostructur
releas
cargo
dendrit
system
use
success
deliv
antitumour
drug
doxorubicin
vivo
passiv
target
recent
allow
direct
deliveri
exploit
modular
dendrim
assembl
enabl
surfac
functionalis
along
common
secondari
structur
adopt
polypeptid
hydrogen
bond
backbon
amid
oxygen
nh
bond
residu
away
induc
righthand
helic
structur
amino
acid
sidechain
direct
away
core
stabilis
achiev
subsequ
assembl
multipl
peptid
form
coiledcoil
motif
wherebi
multipl
helic
wrap
around
superhel
bundl
assembl
driven
first
exclus
hydrophob
residu
form
aqueou
exterior
stabilis
enhanc
interstrand
electrostat
interact
polar
charg
amino
acid
result
assembl
offer
power
mean
produc
complex
bioactiv
materi
found
use
across
rang
disciplin
coiledcoil
peptid
first
use
nanotechnolog
field
steven
et
al
drive
assembl
aunp
higher
order
aggreg
format
applic
np
compos
entir
coiledcoil
peptid
structur
subsequ
driven
group
burkhard
report
ration
structurebas
design
linear
peptid
compos
pentamer
repeat
form
coiledcoil
domain
cartilag
oligomer
matrix
protein
comp
de
novo
design
peptid
form
selfassembl
trimer
peptid
abl
undergo
selfassembl
regular
polyhedr
np
display
multipl
copi
bioactiv
speci
particl
surfac
describ
section
display
capabl
effect
mimick
pathogen
antigen
present
coiledcoil
np
subsequ
therefor
demonstr
act
novel
immunogen
product
vaccin
diseas
includ
sever
acut
respiratori
syndrom
sar
malaria
hiv
figur
develop
enhanc
np
stabil
includ
addit
lipid
tail
format
elastinlik
peptid
hybrid
discuss
addit
report
bring
cac
low
nm
rang
importantli
coiledcoil
core
shown
weakli
immunogen
result
ab
gener
np
predominantli
target
toward
display
antigen
though
low
titr
particl
also
reportedli
gener
nonvir
deliveri
dna
rna
cell
power
emerg
techniqu
treatment
diseas
number
treatment
base
around
deliveri
plasmid
dna
antisens
silenc
micro
rna
current
clinic
even
greater
number
undergo
advanc
clinic
trial
positivelycharg
peptid
abl
selfassembl
compact
np
neg
charg
nucleic
acid
particularli
attract
exploit
research
discuss
throughout
review
peptid
vector
shown
protect
dnarna
cargo
damag
enabl
target
desir
cell
type
perhap
importantli
facilit
intracellular
deliveri
endosom
escap
describ
section
inde
cation
residu
enabl
np
format
lysin
arginin
also
abl
promot
cell
penetr
wu
wu
amongst
first
report
peptidenucl
acid
np
mediat
gene
deliveri
complex
plasmid
dna
polylysin
shown
effici
deliv
cargo
cell
vitro
mani
subsequ
report
focuss
abil
peptidenucl
acid
complex
transfect
isol
cell
rather
appli
vivo
part
due
tradeoff
toxic
associ
longer
cation
peptid
low
particl
stabil
shorter
sequenc
use
instead
stabilis
dialdehyd
crosslink
disulfid
format
report
howev
common
mean
enabl
vivo
applic
use
complex
peptid
substrat
capabl
lower
cac
suffici
overcom
problem
earli
exampl
rittner
et
al
replac
acid
residu
amphiphil
cellpenetr
peptid
cation
lysin
arginin
produc
sequenc
abl
condens
dna
promot
effici
system
transfect
vivo
peptid
mpg
rala
argininerich
analogu
commonli
utilis
endosom
escap
peptid
gala
amphiphil
argininecontain
triblock
peptid
found
use
vivo
deliveri
nucleic
acid
cargo
recent
kaplan
zheng
group
report
target
deliveri
peptidenucl
acid
np
via
introduct
tumourspecif
home
peptid
figur
case
preferenti
accumul
subsequ
nucleic
acid
deliveri
tumour
tissu
achiev
follow
intraven
inject
observ
prevent
potenti
sideeffect
occur
result
system
transfect
elastinlik
polypeptid
elp
biosynthesis
polymericpeptid
repeat
typic
pentamer
sequenc
vpgxg
n
x
n
vari
ultim
determin
properti
particular
elp
construct
elp
possess
invers
transit
temperatur
tt
undergo
sharp
phase
transit
highli
solvat
peptid
monom
desolv
aggreg
exact
properti
determin
socal
guestresidu
hydrophob
residu
lead
decreas
tt
convers
hydrophil
residu
lead
correspond
increas
aggreg
elp
exploit
form
spheric
nanos
cargodeliveri
vehicl
via
number
differ
strategi
simplest
realis
technolog
reli
passiv
accumul
solubl
elp
monom
within
tumour
via
epr
effect
suitabl
design
sequenc
tt
modul
slightli
higher
bodi
temperatur
peptid
selfassembl
driven
site
interest
applic
localis
hyperthermia
process
np
assembl
first
form
abl
promot
cellular
uptak
follow
subsequ
format
larger
aggreg
lead
retent
site
heat
importantli
strategi
requir
precis
control
concentr
systemicallyinject
elp
high
offtarget
aggreg
result
low
assembl
observ
upon
heat
spite
sensit
hyperthermia
induc
assembl
elp
np
still
use
enhanc
activ
attach
drug
doxorubicin
promot
retent
uptak
site
heat
applic
use
amphiphil
elp
structur
form
stabl
micel
tt
recent
report
bring
cac
high
nmlow
rang
earli
exampl
dreher
et
al
demonstr
attach
hydrophob
doxorubicin
endosom
cleavabl
hydrazon
bond
could
drive
micel
format
mackay
et
al
subsequ
show
tune
tt
stabl
structur
low
cac
could
gener
use
effect
treat
tumour
vivo
figur
altern
format
diblock
elp
polym
use
drive
assembl
block
possess
uniqu
tt
temperatur
tt
first
block
beneath
second
micel
format
occur
stabilis
introduct
disulphid
crosslink
elpbas
np
appli
number
applic
recent
year
addit
earli
report
drugdeliveri
elp
subsequ
utilis
nir
fluoresc
imag
agent
micropet
contrast
agent
synthet
vaccin
furthermor
attach
multival
tumour
target
sequenc
cellpenetr
peptid
phrespons
elp
core
seen
enhanc
applic
elpnanostructur
biomedicin
casein
collect
term
famili
phosphoryl
protein
commonli
found
milk
protein
welldefin
hydrophil
ntermin
domain
hydrophob
ctermin
domain
creat
structur
essenc
view
amphiphil
diblock
copolym
unlik
protein
may
form
globular
aggreg
casein
abl
undergo
control
selfassembl
form
stabl
micellelik
structur
aqueou
solut
cac
particularli
true
individu
casein
famili
member
notabl
use
isol
rather
natur
occur
mixtur
casein
micel
recent
subject
increas
interest
natur
occur
nanodeliveri
vehicl
rang
hydrophob
cargo
use
casein
np
improv
bioavail
supplement
vitamin
prior
releas
follow
proteas
action
stomach
subject
human
clinic
trial
similarli
deliveri
hydrophob
therapeut
particularli
treatment
stomach
cancer
wide
studi
livney
group
final
tumour
accumul
intraven
inject
cisplatin
contain
caseinmicel
shown
result
improv
therapeut
outcom
vivo
figur
promis
earli
report
coupl
eas
use
inexpens
product
biodegrad
nontox
nonimmunogen
natur
casein
micel
make
particularli
appeal
deliveryvehicl
like
come
year
see
structur
find
increas
util
biomedicin
np
biosens
complex
offer
power
mean
detect
monitor
diseas
understand
patholog
condit
usual
achiev
use
optic
activ
np
though
sens
modal
also
utilis
common
sens
platform
reli
chang
optic
properti
presenc
desir
analyt
biomark
select
bind
np
complex
within
detectionregion
peptid
protein
vital
compon
system
induc
np
bind
mediat
respons
output
presenc
desir
analyt
np
biosensor
wide
utilis
ex
vivo
analysi
biofluid
epitomis
use
antihuman
chorion
gonadotropin
hcg
antibodi
coat
aunp
commerci
avail
later
flow
pregnanc
test
develop
npbase
biosensor
becom
vast
field
research
detail
overview
ex
vivo
technolog
outsid
scope
review
reader
instead
refer
number
excel
comprehens
review
topic
detail
instead
focu
far
smaller
bodi
literatur
focuss
applic
npbiosensor
vivo
challeng
far
limit
widespread
implement
system
allow
true
complex
tissu
captur
way
vitro
test
biofluid
provid
sens
complex
provid
mean
interrog
biolog
system
probe
differ
activ
tempor
distribut
desir
analyt
oppos
spatial
localis
provid
imag
modal
rather
detect
within
specif
area
vivo
sensor
offer
respons
platform
monitor
small
molecul
biomacromolecul
diseas
state
continu
manner
although
implant
electrochem
sensor
wide
describ
particular
monitor
blood
glucos
level
problem
induc
fibrosi
foreign
bodi
respons
limit
sensit
accuraci
np
base
system
offer
viabl
altern
also
complicationsin
addit
challeng
gener
signal
activ
transduc
detect
np
must
overcom
background
signal
gener
within
complex
environ
bodi
retain
desir
site
detect
ideal
provid
revers
dynam
respons
use
peptideproteinnp
conjug
particular
must
address
sensit
biolog
compon
degrad
clearanc
unfavour
interact
result
system
peptid
protein
play
activ
sens
role
rather
mediat
imag
target
recent
begun
emerg
one
realis
technolog
environment
sensit
polym
np
exploit
detect
differ
analyt
concentr
result
conjug
enzym
activ
specif
polym
np
incorpor
platinum
base
fluoresc
sensor
shown
display
phosphoresc
depend
environment
oxygen
concentr
cash
clark
demonstr
conjug
histaminemetabolis
oxygenconsum
enzym
diamin
oxidas
np
surfac
biolog
relev
level
key
inflammatoryand
neuromodul
could
detect
chang
phosphor
respons
revers
upon
diffus
oxygen
back
biolog
milieu
limit
dropoff
polym
dynam
rang
observ
upon
repeat
applic
similarli
sun
et
al
monitor
glucos
level
vivo
use
glucos
oxidasefunctionalis
oxygenpolym
np
transduc
subcutan
implant
enabl
retent
particl
month
enabl
reproduc
signal
gener
extend
period
altern
bhatia
group
pioneer
use
proteasesensit
np
coat
releas
peptid
cleavag
product
urin
upon
enzymat
activ
vivo
origin
report
kwong
et
al
conjug
peptid
sensit
rang
common
proteas
onto
surfac
iron
oxid
nanoworm
due
size
particl
block
renal
clearanc
display
accumul
liver
howev
follow
proteas
activ
peptid
cleavag
product
excret
urin
could
subsequ
detect
mass
spectrometri
give
panelreadout
vivo
proteas
level
subsequ
iter
technolog
demonstr
detect
thrombosi
colorect
cancer
use
peptid
termin
recognit
element
subsequ
detect
urin
enzymelink
immunosorb
assay
pointofcar
later
flow
detect
system
order
overcom
challeng
present
nonspecif
activ
circul
proteas
dudani
et
al
report
use
photoprotect
peptidenp
coat
could
activ
toward
proteas
sensit
spatial
tempor
control
follow
applic
uv
twophoton
light
furthermor
subcutan
implant
nm
peptidefunctionalis
pegnp
enabl
gradual
leach
particl
reservoir
blood
stream
recent
shown
allow
continu
monitor
proteas
activ
vivo
although
detect
still
limit
hr
time
period
past
year
seen
rapid
increas
develop
nanotechnolog
exploit
polypeptid
context
also
found
increas
favour
structur
function
versatil
peptid
protein
allow
play
import
role
modul
instig
defin
activ
np
construct
review
outlin
key
role
play
polypeptid
coat
structur
compon
demonstr
utilis
improv
efficaci
np
tool
biomed
applic
mani
case
peptid
protein
fulfil
desir
function
offer
import
advantag
though
except
generalis
exist
care
consid
npconjug
design
figur
exampl
eas
peptid
produc
via
solidphas
peptid
synthesi
spp
highli
benefici
well
offer
costeffect
quick
scalabl
product
versatil
spp
enabl
unnatur
chemic
space
explor
facil
introduct
reactiv
handl
proteas
resist
residu
structur
abl
promot
biolog
interact
enabl
figur
c
furthermor
small
size
peptid
enabl
disrupt
np
hydrodynam
diamet
detriment
effect
activ
minimis
creat
dens
access
flexibl
coverag
activ
sequenc
figur
contrast
increas
structur
complex
offer
protein
enabl
npconjug
typic
attain
increas
activ
recognit
albeit
potenti
cost
decreas
biolog
stabil
increas
recognit
reticuloendotheli
system
figur
addit
small
structur
modif
protein
usual
well
toler
without
lead
major
disrupt
activ
correspond
chang
peptid
sequenc
stronger
influenc
conform
activ
potenti
lead
signific
drop
efficaci
nanotechnolog
figur
situat
complic
complex
interplay
peptideprotein
compon
particular
np
core
cargo
applic
deliveri
rout
consider
precis
polypeptid
compon
vital
step
npconjug
design
despit
advanc
made
enabl
effect
target
deliveri
desir
site
action
provid
integr
mean
maintain
activ
act
hijack
exploit
nativ
biolog
pathway
remain
signific
scope
improv
polypeptidenp
technolog
recent
editori
leroux
highlight
number
paper
report
increasingli
creativ
complex
np
system
increas
exponenti
therapeut
translat
remain
disappoint
highlight
challeng
face
nanotechnolog
field
within
realm
peptideproteinnp
conjug
believ
address
follow
issu
vital
enabl
translat
system
biomed
set
use
nativ
amino
acid
bring
threat
proteas
sensit
activ
often
rapidli
lost
complex
environ
face
vivo
review
number
approach
introduc
toward
address
difficulti
unnatur
amino
acid
particularli
effect
provid
peptid
bond
recognis
process
nativ
enzym
easili
achiev
synthet
peptid
discuss
rel
simpl
modif
nmethyl
enantioor
retroenantio
amino
acid
extend
introduc
increas
stabil
harder
achiev
protein
substrat
advent
technolog
allow
introduct
nonnatur
stabilis
residu
addit
protect
polym
coat
format
addit
crosslink
allow
issu
address
order
fulli
facilit
translat
npbase
system
import
research
commun
begin
activ
embrac
technolog
ii
small
size
peptid
allow
form
compact
np
coat
lead
minim
disrupt
desir
function
therefor
often
prefer
choic
design
nppolypeptid
conjug
major
drawback
reduc
bioactiv
figur
e
natur
million
year
slowli
evolv
protein
complex
structur
potent
activ
remain
challeng
design
screen
deriv
peptid
fulli
recapitul
nowher
strongli
felt
reduc
abil
short
synthet
peptid
amino
acid
target
bind
particular
protein
cell
type
compar
ab
bind
protein
although
strongli
bind
long
peptid
affibodi
amino
acid
access
synthet
typic
produc
recombinantli
still
result
bulki
coat
np
surfac
therefor
press
need
technolog
bring
short
peptid
bind
affin
nm
rang
recent
advanc
screen
design
exploit
bicycl
peptid
enabl
level
reach
sure
exploit
near
futur
enhanc
abil
nptarget
strategi
achiev
goal
iii
bioactiv
peptid
proteinnp
conjug
highli
depend
achiev
appropri
access
orient
bioactiv
domain
easier
achiev
use
peptid
rather
protein
substrat
tether
residu
easili
introduc
termini
solid
phase
peptid
synthesi
often
protein
substrat
attach
either
nonspecif
conjug
techniqu
simpl
adsorpt
lead
detriment
loss
structur
heterogen
coat
steric
hindranc
activ
site
essenti
recent
develop
field
sitespecif
select
protein
modif
exploit
overcom
problem
enabl
control
orient
protein
np
surfac
strategi
genet
chemic
manipul
protein
introduc
exploit
uniqu
reactiv
natur
nonnatur
amino
acid
incorpor
hexahistidin
affin
tag
becom
increasingli
widespread
offer
power
tool
biomed
research
commun
iv
mani
applic
peptideproteinnp
conjug
discuss
review
reli
process
still
poorli
understood
fundament
level
controversi
still
exist
precis
mechan
peptid
mediat
transport
across
biolog
barrier
coat
particl
compon
previous
thought
biolog
inert
becom
increasingli
found
induc
immunolog
respons
design
criteria
requir
produc
stabl
selfassembl
polypeptid
np
still
develop
order
provid
np
technolog
meet
challeng
demand
biomed
applic
import
topic
mani
other
within
field
continu
investig
deeper
understand
intertwin
complex
determin
np
fate
provid
v
proper
standardis
characteris
nppeptideprotein
conjug
essenti
allow
progress
field
enabl
regulatori
clinic
standard
met
challeng
must
address
develop
new
tool
abl
reflect
true
natur
np
complex
well
increas
uptak
research
exist
technolog
thorough
approach
np
characteris
taken
present
mani
system
report
literatur
inadequ
characteris
lead
larg
discrep
result
conflict
report
incorrect
interpret
subsequ
propag
throughout
field
inher
complex
npbioconjug
make
undoubtedli
challeng
studyeven
appear
simpl
measur
concentr
particl
solut
often
difficult
becom
even
signific
complex
calcul
densiti
orient
protein
np
surfac
origin
biolog
effect
aris
heterogen
sampl
howev
novel
tool
answer
question
begin
emerg
although
often
highli
specialis
begin
readili
access
research
nation
intern
facil
np
research
characteris
big
leap
toward
enabl
clinic
translat
mani
peptideproteinnp
conjug
technolog
taken
biomed
commun
address
issu
result
abil
treat
diagnos
understand
diseas
greatli
enhanc
allow
nanotechnolog
fulfil
undoubt
promis
biomed
scienc
